Paul Bien

Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections

Philippe Prokocimer, Paul Bien, Joseph Surber et al. · Antimicrobial Agents and Chemotherapy · 2010 · 117 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug

Shawn D. Flanagan, Paul Bien, Kelly A. Muñoz et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2013 · 96 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

<i>In Vitro</i> Activity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections

Philippe Prokocimer, Paul Bien, Carisa DeAnda et al. · Antimicrobial Agents and Chemotherapy · 2012 · 87 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

<i>In Vitro</i> Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017

Michael A. Pfaller, Michael D. Huband, Robert K. Flamm et al. · Antimicrobial Agents and Chemotherapy · 2019 · 82 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris <i>:</i> Results from a Phase 2 Trial

José A. Vázquez, Peter G. Pappas, Kenneth D Boffard et al. · Antimicrobial Agents and Chemotherapy · 2023 · 78 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17